Physician profile
Mark Darwin Mcclintock
NPI 1750384202
$3,531.33
in general payments reported to CMS, 2019-2025
19 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $666 · 2020: $178 · 2021: $334 · 2022: $486 · 2023: $514 · 2024: $972 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,867.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,109.99 | 2019-2025 | Clareon, Tryptyr, Precision7 |
| Bausch & Lomb Americas INC. | $716.84 | 2022-2025 | Xiidra, Infuse, Miebo |
| New World Medical,INC. | $307.10 | 2022-2025 | Clearpath, Streamline, Kahook Dual Blade |
| Glaukos Corporation | $298.90 | 2024 | Idose, Ce-Marked Kxla System |
| Allergan, INC. | $256.79 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $217.59 | 2019-2021 | |
| Abbvie INC. | $114.81 | 2022-2024 | |
| Oyster Point Pharma, INC. | $81.70 | 2022-2024 | Tyrvaya, Ryzumvi |
| Sun Pharmaceutical Industries INC. | $79.11 | 2019-2024 | |
| Biotissue Holdings INC. | $65.21 | 2019-2025 | |
| Aerie Pharmaceuticals, INC. | $62.49 | 2019-2021 | |
| Ocular Therapeutix, INC. | $62.39 | 2022-2024 | Dextenza |
| Johnson & Johnson Vision Care, INC. | $46.75 | 2019-2021 | |
| Akorn, INC. | $21.58 | 2020 | |
| Thea Pharma INC. | $20.27 | 2024 | Iyuzeh |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akorn Operating Company LLC | $20.14 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.20 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.75 | 2019 | |
| Coopervision INC. | $15.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Mcclintock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.